April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden, Garcia Launch Inquiry into Shady Groups Awarded $394 Million in Contracts by Trump Administration to Represent Unaccompanied Minors
- Wyden Questions Customs and Border Protection Over Favorable Treatment of Dominican Corporation’s Sugar Imports Despite Clear Evidence of Ongoing Forced Labor
- Wyden, Warren Demand FINRA Strengthen Cybersecurity Standards to Prevent ACATS Brokerage Fraud
- Wyden Demands Answers on Millions in Payments to Trump Businesses By Korean Company Involved in Trade Dispute
- Wyden Questions Whether Gift of Diamond-Encrusted Gold Ring to Trump Corruptly Influenced Trump’s Decision to Let Belgium Diamond Industry Dodge New Tariffs